Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125516351 | 12551635 | 1 | I | 20160707 | 20160713 | 20160713 | EXP | IN-ALEMBIC PHARMACUETICALS LIMITED-2016SCAL000567 | ALEMBIC | DHAKNE R, MISHRA K K, KUMAR V, KHAIRKAR P. PROLONGED APNEA DURING MODIFIED ELECTROCONVULSIVE THERAPY IN A PATIENT OF SUICIDAL ATTEMPT BY ORGANOPHOSPHORUS POISONING A CASE REPORT. JOURNAL OF ECT. 2016;32 (2):136-138 | 0.00 | Y | 0.00000 | 20160713 | MD | IN | IN |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125516351 | 12551635 | 1 | PS | LITHIUM CARBONATE. | LITHIUM CARBONATE | 1 | 600 MG, QD | Y | 79159 | 600 | MG | ||||||||
| 125516351 | 12551635 | 2 | I | LITHIUM CARBONATE. | LITHIUM CARBONATE | 1 | 600 MG, QD, RESTARTED | Y | 79159 | 600 | MG | ||||||||
| 125516351 | 12551635 | 3 | I | SUCCINYLCHOLINE | SUCCINYLCHOLINE | 1 | 75 MG, UNK | U | 0 | 75 | MG | ||||||||
| 125516351 | 12551635 | 4 | C | OLANZAPINE. | OLANZAPINE | 1 | 15 MG, QD | 0 | 15 | MG | TABLET | ||||||||
| 125516351 | 12551635 | 5 | C | ONDANSETRON | ONDANSETRON | 1 | 4 MG, UNK | 0 | 4 | MG | |||||||||
| 125516351 | 12551635 | 6 | C | GLYCOPYRROLATE /00196201/ | GLYCOPYRRONIUM | 1 | 2 MG, UNK | 0 | 2 | MG | |||||||||
| 125516351 | 12551635 | 7 | C | PENTAZOCINE | PENTAZOCINE | 1 | 7.5 MG, UNK | 0 | 7.5 | MG | INJECTION | ||||||||
| 125516351 | 12551635 | 8 | C | PENTAZOCINE | PENTAZOCINE | 1 | 0 | INJECTION | |||||||||||
| 125516351 | 12551635 | 9 | C | PROPOFOL. | PROPOFOL | 1 | Intravenous (not otherwise specified) | 100 MG, UNK | 0 | 100 | MG | ||||||||
| 125516351 | 12551635 | 10 | C | DEXTROSE. | DEXTROSE | 1 | 25 %, UNK | 0 | 25 | PCT | INJECTION | ||||||||
| 125516351 | 12551635 | 11 | C | MIDAZOLAM | MIDAZOLAMMIDAZOLAM HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | 1 MG, UNK | 0 | 1 | MG | INJECTION | |||||||
| 125516351 | 12551635 | 12 | C | MIDAZOLAM | MIDAZOLAMMIDAZOLAM HYDROCHLORIDE | 1 | 0 | INJECTION | |||||||||||
| 125516351 | 12551635 | 13 | C | ORGANOPHOSPHOROUS COMPOUNDS | 2 | 200 ML, UNK | 0 | 200 | ML | ||||||||||
| 125516351 | 12551635 | 14 | C | FRESH FROZEN PLASMA | HUMAN PLASMA | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125516351 | 12551635 | 1 | Bipolar disorder |
| 125516351 | 12551635 | 3 | Neuromuscular blockade |
| 125516351 | 12551635 | 4 | Product used for unknown indication |
| 125516351 | 12551635 | 5 | Product used for unknown indication |
| 125516351 | 12551635 | 6 | Product used for unknown indication |
| 125516351 | 12551635 | 7 | Cough |
| 125516351 | 12551635 | 8 | Pain |
| 125516351 | 12551635 | 9 | Anaesthesia |
| 125516351 | 12551635 | 10 | Product used for unknown indication |
| 125516351 | 12551635 | 11 | Sedation |
| 125516351 | 12551635 | 12 | Anxiety |
| 125516351 | 12551635 | 13 | Suicide attempt |
| 125516351 | 12551635 | 14 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125516351 | 12551635 | HO |
| 125516351 | 12551635 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125516351 | 12551635 | Apnoea | |
| 125516351 | 12551635 | Drug interaction |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |